Evidence map›Paper›PMID 39955061›Full record

ArticleThe Journal of biological chemistry2025

Anaplerosis by medium-chain fatty acids through complex interplay with glucose and glutamine metabolism.

Hannah M German, Jolita Ciapaite, Nanda M Verhoeven-Duif, Judith J M Jans

Abstract read
In one paragraph

Article in The Journal of biological chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Molecular and cellular mechanisms of pentadecanoic acid.World journal of biological chemistry · 2025
    Review
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Hannah M GermanSection Metabolic Diagnostics, Department of Genetics, University Medical Centre Utrecht, Utrecht University, Utrechts, the Netherlands; United for Metabolic Diseases, the Netherlands. Electronic address: H.M.German@umcutrecht.nl.
Jolita CiapaiteSection Metabolic Diagnostics, Department of Genetics, University Medical Centre Utrecht, Utrecht University, Utrechts, the Netherlands; United for Metabolic Diseases, the Netherlands.
Nanda M Verhoeven-DuifSection Metabolic Diagnostics, Department of Genetics, University Medical Centre Utrecht, Utrecht University, Utrechts, the Netherlands; United for Metabolic Diseases, the Netherlands.
Judith J M JansSection Metabolic Diagnostics, Department of Genetics, University Medical Centre Utrecht, Utrecht University, Utrechts, the Netherlands; United for Metabolic Diseases, the Netherlands. Electronic address: J.J.M.Jans@umcutrecht.nl.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The constant replenishment of tricarboxylic acid (TCA) cycle intermediates, or anaplerosis, is crucial to ensure optimal TCA cycle activity in times of high biosynthetic demand. In inborn metabolic diseases, anaplerosis is often affected, leading to impaired TCA cycle flux and ATP production. In these cases, anaplerotic compounds can be a therapy option. Triheptanoin, a triglyceride containing three heptanoate chains, is thought to be anaplerotic through production of propionyl- and acetyl-CoA. However, the precise mechanism underlying its anaplerotic action remains poorly understood. In this study, we performed a comprehensive in vitro analysis of heptanoate metabolism and compared it to that of octanoate, an even-chain fatty acid which only provides acetyl-CoA. Using stable isotope tracing, we demonstrate that both heptanoate and octanoate contribute carbon to the TCA cycle in HEK293 T cells, confirming direct anaplerosis. Furthermore, by using labeled glucose and glutamine, we show that heptanoate and octanoate decrease the contribution of glucose-derived carbon and increase the influx of glutamine-derived carbon into the TCA cycle. Our findings also point towards a change in redox homeostasis, indicated by an increased NAD

Indexed as

Citric Acid CycleFatty AcidsGlucoseGlutamineAcetyl Coenzyme ACaprylatesHEK293 CellsHumansOxidation-ReductionTriglyceridesAcetyl Coenzyme ACaprylatesFatty AcidsGlucoseGlutamineoctanoic acidTriglyceridestriheptanoinAnaplerosisFatty acidsIsotopic tracerMass spectrometry (MS)Metabolic diseaseMetabolomicsRedox regulation

Identifiers

PMID39955061
PMCPMC12020922

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.